Dhanya Dharman | Pharmacology | Best Research Article Award

Published on by Best Paper Awards

Best Research Article Award

Dhanya Dharman
Dr Moopens College of Pharmacy, India
Paper Title: Effectiveness of mometasone, indacaterol, glycopyrronium (once daily single inhaler triple therapy) in the management of severe asthma: a prospective observational study

Dhanya Dharman
Affiliation Dr Moopens College of Pharmacy
Country India
Documents 53
Citations 37
h-index 4
Subject Area Pharmacology
Event International Research Excellence and Best Paper Awards
Google Scholar GausjtcAAAAJ&hl=en

Dhanya Dharman is a researcher affiliated with Dr Moopens College of Pharmacy, India, whose scholarly record includes 53 documents and 37 citations, with a reported h-index of 4. The research profile is situated within pharmacology and includes work examining therapeutic approaches for severe asthma, including single-inhaler triple therapy. [1]

Abstract

Dhanya Dharman is a pharmacology researcher affiliated with Dr Moopens College of Pharmacy in India. Her documented research profile comprises 53 scholarly documents, 37 citations, and an h-index of 4. A relevant research contribution examines the effectiveness of mometasone, indacaterol, and glycopyrronium, administered once daily through a single inhaler, for managing severe asthma. The prospective observational study addresses clinical treatment effectiveness within a real-world patient context and contributes to evidence concerning inhaled corticosteroid, long-acting beta2-agonist, and long-acting muscarinic antagonist combinations. The work reflects an applied pharmacological perspective focused on therapeutic management, treatment response, and respiratory disease care. [1]

Keywords

Severe asthma; triple therapy; mometasone; indacaterol; glycopyrronium; inhaler therapy; pharmacology; respiratory medicine; prospective observational study; asthma management.

Introduction

Severe asthma can require intensified pharmacological management when conventional treatment does not provide adequate control. Inhaled corticosteroids combined with long-acting bronchodilators are established therapeutic approaches, while triple therapy adds a long-acting muscarinic antagonist. The submitted study investigates this combination in a prospective observational setting. [1]

Research Profile

The supplied bibliometric record identifies 53 documents, 37 citations, and an h-index of 4 for Dhanya Dharman. These indicators provide a quantitative description of indexed scholarly output and citation activity, although bibliometric measures should be interpreted alongside publication quality, research context, authorship, and field-specific citation practices. [1]

Research Contributions

The principal research contribution identified for this recognition concerns the prospective observational assessment of once-daily single-inhaler triple therapy containing mometasone, indacaterol, and glycopyrronium. The study focuses on severe asthma management and provides clinical observations relevant to evaluating combined inhaled pharmacotherapy in routine treatment environments. [2]

Publications

The supplied record reports 53 documents associated with the researcher. The specifically identified paper is titled Effectiveness of mometasone, indacaterol, glycopyrronium (once daily single inhaler triple therapy) in the management of severe asthma: a prospective observational study. Complete bibliographic metadata, including journal, publication year, DOI, and author list, was not supplied and should therefore be verified before formal citation. [1]

Research Impact

The reported 37 citations indicate that the research output has received scholarly references in subsequent literature. Citation counts are indicators of academic visibility rather than direct measures of clinical effectiveness or societal benefit. The identified asthma research may be relevant to discussions of inhaled triple therapy and severe respiratory disease management. [1]

Award Suitability

The documented research aligns with the academic scope of a Best Research Article Award through its focus on a defined pharmacological intervention and a clinically relevant respiratory condition. Consideration may include methodological design, clarity of objectives, evidence quality, originality, relevance to pharmacology, and the completeness of supporting publication documentation. [2]

Conclusion

Dhanya Dharman’s supplied research profile documents scholarly activity in pharmacology and includes research addressing severe asthma treatment. The identified prospective observational study examines once-daily single-inhaler triple therapy involving mometasone, indacaterol, and glycopyrronium. Its subject focus provides a relevant basis for academic recognition within pharmacological and respiratory research. [1]

References

    1. Ramesan, R. (n.d.). Google Scholar profile. Google Scholar.
      Google Scholar Profile

    2. The era of pharmacovigilance and the need of pharmacovigilance in psychiatry: A review.
      https://www.researchgate.net/publication/331268791_The_era_of_pharmacovigilance_and_the_need_of_pharmacovigilance_in_psychiatry_A_review

    3. A cross sectional study of polycystic ovarian syndrome among pharmacy students.
      https://www.researchgate.net/publication/339282966_A_cross_sectional_study_of_polycystic_ovarian_syndrome_among_pharmacy_students

Pradeep Kumar | Pharmacology, Toxicology and Pharmaceutical Science | Best Paper Award

Published on by Best Paper Awards

Best Paper Award

Insights into the Biological Activities and Substituent Effects of Pyrrole Derivatives: The Chemistry-Biology Connection.
Pradeep Kumar
Affiliation KLE College of Pharmacy, Hubli
Country India
Article Title Insights into the Biological Activities and Substituent Effects of Pyrrole Derivatives: The Chemistry-Biology Connection
Scopus ID 57206689423
Article Type Review Article
Article Views 713
Reference Count 105
Award Category Best Paper Award
Event International Research Excellence and Best Paper Awards
ORCID 0000-0003-4033-8877

Pradeep Kumar, affiliated with KLE College of Pharmacy, Hubli, India, has been recognized under the Best Paper Award category for the scholarly article titled “Insights into the Biological Activities and Substituent Effects of Pyrrole Derivatives: The Chemistry-Biology Connection”. Published in 2024 through Wiley Online Library, the article presents a comprehensive review of pyrrole derivatives, emphasizing their pharmacological relevance, structure–activity relationships, and the influence of chemical substituents on biological performance. The work contributes to medicinal chemistry by integrating chemical and biological perspectives into a unified scientific framework.[1]

Abstract

This review article examines the chemistry and biological significance of pyrrole derivatives, a class of heterocyclic compounds widely investigated in medicinal chemistry. The study discusses structural modifications, substituent effects, and their influence on pharmacological properties including antimicrobial, anticancer, anti-inflammatory, antioxidant, and antiviral activities. Particular attention is given to structure–activity relationships that guide the rational design of bioactive molecules. By consolidating findings from diverse studies, the review highlights emerging trends, therapeutic opportunities, and future directions for pyrrole-based drug discovery. The article serves as a valuable scientific resource for researchers exploring innovative medicinal applications of pyrrole-containing compounds.[2]

Keywords

Pyrrole derivatives; Medicinal chemistry; Structure–activity relationship; Drug discovery; Heterocyclic compounds; Biological activity; Substituent effects; Pharmacological properties.

Introduction

Pyrrole derivatives occupy an important position in pharmaceutical and medicinal chemistry because of their presence in numerous natural products, therapeutic agents, and biologically active molecules. Understanding how chemical modifications affect biological activity remains essential for designing safer and more effective drug candidates. The reviewed article addresses this challenge by examining the relationship between molecular structure and pharmacological performance across diverse pyrrole-based compounds.[2]

Research Profile

Pradeep Kumar is associated with KLE College of Pharmacy, Hubli, India. His academic interests include medicinal chemistry, pharmaceutical sciences, heterocyclic chemistry, and bioactive molecular design. Through scholarly publications and scientific investigations, he has contributed to advancing knowledge regarding the therapeutic potential of chemically modified compounds and their applications in modern drug development.[1]

Scientific Background

Heterocyclic compounds constitute a significant proportion of approved pharmaceuticals. Pyrrole-containing molecules are especially important because their electronic properties and structural flexibility facilitate interactions with biological targets. Previous research has demonstrated that subtle substituent changes can significantly alter potency, selectivity, and pharmacokinetic characteristics. Consequently, comprehensive evaluations of substituent effects are essential for understanding molecular behavior and optimizing therapeutic outcomes.[3]

Methodology

The article adopts a systematic review-based methodology by collecting, analyzing, and synthesizing published scientific literature related to pyrrole derivatives. Research findings from medicinal chemistry, pharmacology, and drug discovery studies were comparatively evaluated to identify recurring structure–activity relationships. The approach enables comprehensive assessment of biological activities while providing an integrated understanding of how molecular substitutions influence pharmacological responses.[2]

Key Findings

The review demonstrates that biological activity in pyrrole derivatives is strongly influenced by substituent type, position, and electronic characteristics. Specific structural modifications were associated with improved antimicrobial, anticancer, antioxidant, and anti-inflammatory effects. The study further identifies molecular patterns that may enhance target specificity and therapeutic efficacy. These observations provide valuable guidance for future medicinal chemistry programs seeking optimized pyrrole-based drug candidates.[2]

Scientific Contributions

A major contribution of this article is the consolidation of extensive evidence regarding pyrrole derivative bioactivity into a single scholarly resource. The review provides a structured interpretation of substituent effects, facilitating better understanding of molecular design strategies. Its interdisciplinary perspective bridges chemistry and biology, supporting researchers involved in drug discovery, pharmacological evaluation, and rational therapeutic development.[4]

Conclusion

The recognized article provides a comprehensive examination of pyrrole derivatives and their diverse biological activities. By highlighting the influence of structural modifications on pharmacological behavior, the study contributes meaningful insights to medicinal chemistry research. Its synthesis of current scientific knowledge offers practical guidance for future investigations aimed at developing effective pyrrole-based therapeutic agents and expanding the understanding of chemistry–biology relationships.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Pradeep Kumar, Author ID 57206689423. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57206689423
  2. Kumar, P. (2024). Insights into the Biological Activities and Substituent Effects of Pyrrole Derivatives: The Chemistry-Biology Connection. Chemistry & Biodiversity.
    DOI: https://doi.org/10.1002/cbdv.202400534
  3. Wiley Online Library. (2024). Article abstract and publication information.
    https://onlinelibrary.wiley.com/doi/abs/10.1002/cbdv.202400534
  4. Wiley Online Library. (2024). Chemistry & Biodiversity Journal.
    https://onlinelibrary.wiley.com/journal/16121880/
  5. International Research Excellence and Best Paper Awards. (2026). Best Paper Award Recognition Program.
    https://bestpaperawards.com/

Krishnaveni Manubolu | Pharmaceutical Sciences | Research Excellence Award

Published on by Best Paper Awards

Research Excellence Award

KRISHNAVENI MANUBOLU
Narayana Pharmacy College

KRISHNAVENI MANUBOLU
Affiliation Narayana Pharmacy College
Country India
Scopus ID 57222627724
Documents 29
Citations 112
h-index 7
Subject Area Pharmaceutical Sciences
Event Best Paper Awards
ORCID 0000-0002-9401-1768

KRISHNAVENI MANUBOLU is a researcher affiliated with Narayana Pharmacy College, India, whose work in pharmaceutical sciences has contributed to advancing knowledge in drug development, formulation science, and therapeutic evaluation. Her academic contributions are reflected through peer-reviewed publications indexed in international databases, demonstrating consistent scholarly engagement and research productivity [1].

Abstract

This article presents an academic overview of KRISHNAVENI MANUBOLU, highlighting her research achievements, publication record, and contributions to pharmaceutical sciences. The evaluation emphasizes her scholarly productivity, citation metrics, and alignment with criteria for research excellence recognition [1].

Keywords

  • Pharmaceutical Sciences
  • Drug Development
  • Research Impact
  • Academic Publications
  • Scopus Metrics

Introduction

Research excellence awards recognize scholars who demonstrate consistent contributions to scientific advancement. KRISHNAVENI MANUBOLU’s academic profile reflects a commitment to pharmaceutical research, supported by peer-reviewed outputs and citation-based impact indicators [1].

Research Profile

Her research profile includes 29 indexed documents with 112 citations and an h-index of 7, indicating moderate but steady scholarly influence within pharmaceutical sciences. These metrics are commonly used to assess research productivity and citation impact in academic evaluations [1].

Research Contributions

KRISHNAVENI MANUBOLU has contributed to areas such as pharmaceutical formulation, drug delivery systems, and therapeutic studies. Her work supports advancements in healthcare applications and contributes to ongoing research efforts in pharmaceutical sciences [2].

Publications

Her publication record includes articles in peer-reviewed journals indexed in international databases. These publications contribute to the dissemination of pharmaceutical research findings and support academic collaboration and citation growth [2].

Research Impact

The citation count and h-index reflect the measurable influence of her work. These indicators suggest engagement with the research community and the relevance of her studies within the pharmaceutical domain [1].

Award Suitability

Based on her academic output, citation metrics, and subject specialization, KRISHNAVENI MANUBOLU demonstrates eligibility for research excellence recognition. Her contributions align with evaluation criteria commonly applied in academic award assessments.

Conclusion

KRISHNAVENI MANUBOLU’s academic profile reflects consistent research engagement and contribution to pharmaceutical sciences. Her publication record and citation metrics support her recognition within the academic community and justify consideration for research excellence awards.

References

  1. Elsevier. (n.d.). Scopus author details: KRISHNAVENI MANUBOLU, Author ID 57222627724. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57222627724

  2. Metal Oxide Nanocatalysts: Eco-friendly Solutions for Catalysis in Green Chemistry.
    https://onlinelibrary.wiley.com/doi/abs/10.1002/9783527853892.ch17

  3. A Short Guide to Clinical Pharmacokinetics.
    https://link.springer.com/book/10.1007/978-981-97-4283-7

  4. Best Paper Awards. (n.d.). Research excellence evaluation criteria.
    https://bestpaperawards.com/

Mukesh Ratnaparkhi | Pharmacology | Best Researcher Award

Published on by Best Paper Awards

Dr. Mukesh Ratnaparkhi | Pharmacology | Best Researcher Award 

Professor | Marathwada Mitramandals College of Pharmacy | India

Dr. Mukesh P. Ratnaparkhi, a distinguished pharmaceutical scientist with over 19 years of academic and research experience, demonstrates strong suitability for a Best Researcher Award through his extensive contributions to pharmaceutics, drug delivery systems, and formulation science. Currently serving as a Professor in Pharmaceutics at Marathwada Mitra Mandal’s College of Pharmacy, Pune, he has progressed through roles of increasing responsibility and is an approved Associate Professor, postgraduate teacher, and Ph.D. research guide under Savitribai Phule Pune University. His academic foundation includes a Ph.D. in Pharmaceutical Sciences and a Master’s degree in Pharmaceutics, complementing his long-standing commitment to research. Dr. Ratnaparkhi has an impressive research portfolio with 74 publications in reputed Scopus, Web of Science, UGC Care, and international indexed journals, addressing critical pharmaceutical challenges such as solubility enhancement, nanoformulations, targeted pulmonary delivery, nasal drug delivery, and advanced drug dispersion techniques. His work spans nanosponge systems, nanoemulgels, cubosomes, solid dispersions, and dry powder inhalation formulations, signifying his expertise in innovative and translational drug delivery approaches. He holds four patents (three granted and one filed), demonstrating originality and innovation, and has guided or collaborated on numerous research projects. Complementing his publication record, he has delivered 31 scientific presentations at national and international conferences, showcasing the continued relevance and impact of his research. His professional strengths include excellent communication, leadership, team management, and a strong research orientation, supported by early industrial training that broadened his practical understanding of pharmaceutical processes. With nearly two decades of academic service, consistent research productivity, significant innovation, mentorship roles, and contributions that influence modern drug delivery systems, Dr. Ratnaparkhi exemplifies the qualities of a high-impact researcher and stands as a strong candidate for the Best Researcher Award.

Profiles: Google Scholar | ORCID | Scopus | ResearchGate | LinkedIn

Featured Publications

  1. Ratnaparkhi, M. P., & Suryawanshi, A. N. (2025). Development and characterization of novel cilnidipine-loaded nanosponge formulations. International Journal of Drug Delivery Technology, 15(3), 1198–1204.

  2. Kshirsagar, S. D., & Ratnaparkhi, M. (2025). Formulation and evaluation of propolis loaded nanosponges based topical anti-inflammatory gel. Indian Journal of Pharmaceutical Education and Research, 59(4), 1–11.

  3. Tekade, A., Ratnaparkhi, M., Shewale, A., Shinde, R., Kulkarni, G., & Pawar, P. (2025). Design and assessment of in situ nasal gel incorporated with nanostructured cubosomes for the targeted therapy of schizophrenia. Journal of Research in Pharmacy, 29(3), 947–958.

  4. Ratnaparkhi, M., Binawade, B., Salvankar, S., Aswar, M., Jadhav, P., Parhad, P., Bhangare, S., & Dalvi, S. (2025). Intravaginal administration of metformin HCl loaded nanoemulgel for treatment of PCOS: In-vitro and in-vivo study. Brazilian Journal of Pharmaceutical Sciences.

  5. Ratnaparkhi, M. P., Tekade, A. R., Salvankar, S. S., Dalvi, S. D., Kulkarni, G. M., & Markand, M. G. (2025). RP-HPLC method development and validation for the quantification of remdesivir IV formulation. Indian Drug, 62(6), 45–49.

Dr. Ratnaparkhi’s research advances innovative drug-delivery systems that enhance therapeutic efficiency and patient outcomes. His work contributes to modern pharmaceutical science by translating nanotechnology-based formulations into practical healthcare solutions with global impact.

Pharmacology

Published on by Best Paper Awards

Introduction of Pharmacology:

Pharmacology research is at the heart of understanding how drugs and substances interact with the human body.

Drug Discovery and Development:

Investigating the identification, design, and development of new drugs and therapies to treat a wide range of medical conditions.

Pharmacokinetics and Pharmacodynamics:

Studying how drugs are absorbed, distributed, metabolized, and eliminated in the body and how they exert their effects.

Toxicology:

Analyzing the adverse effects of drugs and chemical on living organisms, including risk assessment and safety evaluation.

Pharmacogenomics:

Exploring the genetic factors influencing drug responses and tailoring treatments to individual genetic profiles for personalized medicine.

Neuropharmacology:

Investigating the effects of drugs on the nervous system, including the development of medications for neurological and psychiatric disorders.